Virginia Health Center COVID-19 Survey Summary Report

Latest data from September 24, 2021

Number of Health Center respondents = 18 (69% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 5,567
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 43.33%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 655
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 32.10%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 53.19% 64.58%
White, Hispanic/Latino Patients 11.17% 6.41%
Black/African American, Non-Hispanic/Latino Patients 20.57% 17.71%
Black/African American, Hispanic/Latino Patients 0.49% 0.61%
Asian Patients3 1.15% 0.61%
American Indian/Alaska Native Patients3 0.52% 0.31%
Native Hawaiian/Other Pacific Islander Patients3 0.36% 0.00%
Patients with More than one race3 1.13% 0.61%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 5.28% 4.27%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.02% 1.37%
Unreported/Refused to Report Race and Ethnicity 5.12% 3.51%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 942
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 64.31%
COVID-19 Immunization Series Completed 1,143
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 70.30%
COVID-19 Immunization Series Additional 174
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 45.96%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 32.17% 27.21% 50.00%
White, Hispanic/Latino Patients 23.14% 24.15% 13.22%
Black/African American, Non-Hispanic/Latino Patients 24.52% 26.07% 12.07%
Black/African American, Hispanic/Latino Patients 0.42% 0.17% 0.57%
Asian Patients3 1.38% 0.61% 5.17%
American Indian/Alaska Native Patients3 0.32% 1.14% 8.62%
Native Hawaiian/Other Pacific Islander Patients3 0.21% 0.52% 0.00%
Patients with More than one race3 0.42% 0.52% 0.57%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 7.54% 11.20% 2.30%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.70% 1.14% 4.02%
Unreported/Refused to Report Race and Ethnicity 8.17% 7.26% 3.45%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 22.22%
1 to 24 Hours 33.33%
More Than 24 Hours 44.44%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 5.56%
Staffing to administer the vaccine 16.67%
Vaccine confidence 38.89%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 22.22%
None 33.33%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 89.72%
Average Percent of Health Center Visits Conducted Virtually 13.61%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 44.44%
Number of Mobile Van Sites 22
Number of Pop-up Clinics 12
Number of School-Based Vaccination Sites 2

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 33.33%
None 66.67%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 16.67%
Patient awareness/education 0.00%
Staffing capacity 22.22%
Therapy administration/onsite logistics 22.22%
Other 16.67%
None 33.33%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021